Gene therapies for mucopolysaccharidoses
Journal of Inherited Metabolic Disease · 2024-01 · 47 (1) · 135-144
DOI: 10.1002/jimd.12626 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 29.05.2023. Verfasst von Alessandro Rossi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Federico II University of Naples, Naples, Italy. Hauptthemen laut MEDLINE: Mucopolysaccharidoses, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Telethon Foundation ETS, Isaac Foundation.
Abstract (Originalsprache)
Current specific treatments for mucopolysaccharidoses (MPSs) include enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT). Both treatments are hampered by several limitations, including lack of efficacy on brain and skeletal manifestations, need for lifelong injections, and high costs. Therefore, more effective treatments are needed. Gene therapy in MPSs is aimed at obtaining high levels of the therapeutic enzyme in multiple tissues either by engrafted gene‐modified hematopoietic stem progenitor cells (ex vivo) or by direct infusion of a viral vector expressing the therapeutic gene (in vivo). This review focuses on the most recent clinical progress in gene therapies for MPSs. The various gene therapy approaches with their strengths and limitations are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Medicine, Federico II University of Naples, Naples, Italy.
- Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
- Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program, University of Naples Federico II, Naples, Italy.
ORCID-Profile: Alessandro Rossi, Nicola Brunetti-Pierri
Förderung
- Telethon Foundation ETS
- Isaac Foundation
Zitieren
APA
Rossi, A., & Brunetti-Pierri, N. (2024). Gene therapies for mucopolysaccharidoses. Journal of Inherited Metabolic Disease, 47(1), 135-144. https://doi.org/10.1002/jimd.12626
Vancouver
Rossi A, Brunetti-Pierri N. Gene therapies for mucopolysaccharidoses. Journal of Inherited Metabolic Disease. 2024;47(1):135-144. doi:10.1002/jimd.12626
BibTeX
@article{Rossi2024,
author = {Rossi, Alessandro and Brunetti-Pierri, Nicola},
title = {Gene therapies for mucopolysaccharidoses},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
volume = {47},
number = {1},
pages = {135--144},
doi = {10.1002/jimd.12626}
}
EUVIMED